Industry Developments

Reuters has reported that General Electric (GE) will acquire medical device maker Vital Signs for US$860mn.

According to the New York Times, the US Food and Drug Administration (FDA) is expected to release an advisory recommending that doctors conduct a genetic test on patients with HIV/AIDS... 2008-07-28

Teva Pharmaceutical has started commercial shipment of 25mg, 100mg, 150mg and 200mg doses of its generic version of Glaxosmithkline (GSK)'s Lamictal (lamotrigine) in the US.

The Associated Press has reported that the Pharmaceutical Laboratory of Pernambuco will provide child-sized doses for Chagas disease, eliminating the need to divide adult-sized... 2008-07-24

According Raquel Child, Advisor in HIV Prevention at the United Nations Population Fund (UNFPA), a lack of 'sexual knowledge' is the chief cause of HIV/AIDS among the youth of Latin... 2008-07-23

Informa has reported that the Canadian government will invest US$1mn to establish a network of pharmaceutical research centres that will assess the safety and effectiveness of drugs... 2008-07-21

USA TODAY quoted three of the USA's largest medical diagnostic labs stating that vitamin D tests have grown rapidly over the past two years after many research publications linked... 2008-07-17

Informa has reported that new clinical trial regulations in Brazil will make trial sponsors accountable for monitoring trials.

The Pharmaceutical Research & Manufacturers of America's (PhRMA) new voluntary code of conduct has increased the restrictions on drug companies' promotional activities.

The Federation of Health Professionals of Argentina (Fesprosa) has called for an investigation by the country's pharmaceutical regulator ANMAT into an ongoing phase IIIb clinical... 2008-07-15